Pfizer’s Lipitor patent rejected by patent court

Published: 2008-07-01 06:56:00
Updated: 2008-07-01 06:56:00
The Patent Court of Korea has made its ruling against two patents that Pfizer holds on Lipitor, its top-selling cholesterol drug.

Despite the court’s rejection over Lipitor patents, Pfizer Korea said it will appeal the case to the Supreme Court.

Lipitor is the best-selling drug in the world...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.